Alpha Teknova (TKNO) Treasury Shares (2022 - 2026)
Alpha Teknova's (TKNO) quarterly Treasury Shares came in at $22.5 million in Q1 2026, down 78.55% year-on-year from $105.1 million in Q1 2025, and down 50.0% on a QoQ basis from $45.1 million in Q4 2025.
Alpha Teknova (TKNO) Treasury Shares (2022 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 5 years of Treasury Shares data on file, last reported at $22.5 million in Q1 2026.
- On a quarterly basis, Treasury Shares fell 78.55% year-over-year to $22.5 million in Q1 2026; TTM through Mar 2026 was $22.5 million, a 78.55% decrease from a year earlier, with the FY2025 full-year figure at $45.1 million, up 35220.62% from the prior year.
- Treasury Shares for Q1 2026 stood at $22.5 million, down from $45.1 million in the prior quarter.
- Over the last five years, Treasury Shares for TKNO reached as high as $105.1 million in Q1 2025 and fell as low as $28071.0 in Q2 2022.
- Historically, Treasury Shares has averaged $16.5 million across 5 years, with a median of $151000.5 in 2023.
- Across the five-year window, Treasury Shares jumped 99740.37% in 2025 and sank 78.55% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $28071.0 in 2022, then soared by 454.95% to $155780.0 in 2023, then dropped by 18.08% to $127611.0 in 2024, then jumped by 35220.62% to $45.1 million in 2025, then slumped by 50.0% to $22.5 million in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $22.5 million in Q1 2026, $45.1 million in Q4 2025, and $45.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 22.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.54 Mn |
| Mar 31, 2026 | 22.54 Mn |
| Dec 31, 2025 | 45.07 Mn |
| Dec 31, 2025 | 45.07 Mn |
| Sep 30, 2025 | 45.07 Mn |
| Sep 30, 2025 | 45.07 Mn |
| Jun 30, 2025 | 45.07 Mn |
| Jun 30, 2025 | 45.07 Mn |
| Mar 31, 2025 | 105.07 Mn |
| Mar 31, 2025 | 105.07 Mn |
| Dec 31, 2024 | 127,611.00 |
| Dec 31, 2024 | 127,611.00 |
| Sep 30, 2024 | 127,611.00 |
| Sep 30, 2024 | 127,611.00 |
| Jun 30, 2024 | 127,611.00 |
| Jun 30, 2024 | 127,611.00 |
| Mar 31, 2024 | 105,241.00 |
| Mar 31, 2024 | 105,241.00 |
| Dec 31, 2023 | 155,780.00 |
| Dec 31, 2023 | 155,780.00 |